127 related articles for article (PubMed ID: 12819930)
1. Structural development of synthetic retinoids and thalidomide-related molecules.
Hashimoto Y
Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S16-23. PubMed ID: 12819930
[TBL] [Abstract][Full Text] [Related]
2. Structural development of biological response modifiers based on retinoids and thalidomide.
Hashimoto Y
Mini Rev Med Chem; 2002 Dec; 2(6):543-51. PubMed ID: 12370039
[TBL] [Abstract][Full Text] [Related]
3. Retinoids and their nuclear receptors.
Hashimoto Y; Shudo K
Cell Biol Rev; 1991; 25(3):209-35. PubMed ID: 1662552
[TBL] [Abstract][Full Text] [Related]
4. Design of selective nuclear receptor modulators: RAR and RXR as a case study.
de Lera AR; Bourguet W; Altucci L; Gronemeyer H
Nat Rev Drug Discov; 2007 Oct; 6(10):811-20. PubMed ID: 17906643
[TBL] [Abstract][Full Text] [Related]
5. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
6. Thalidomide as a multi-template for development of biologically active compounds.
Hashimoto Y
Arch Pharm (Weinheim); 2008 Sep; 341(9):536-47. PubMed ID: 18389516
[TBL] [Abstract][Full Text] [Related]
7. Novel synthetic retinoids and separation of the pleiotropic retinoidal activities.
Kagechika H
Curr Med Chem; 2002 Mar; 9(5):591-608. PubMed ID: 11945126
[TBL] [Abstract][Full Text] [Related]
8. [Recent advances in retinoids studies].
Kagechika H; Hashimoto Y; Kawachi E; Shudo K
Gan To Kagaku Ryoho; 1988 Oct; 15(10):2839-47. PubMed ID: 3052300
[TBL] [Abstract][Full Text] [Related]
9. Retinoid ameliorates experimental autoimmune myositis, with modulation of Th cell differentiation and antibody production in vivo.
Ohyanagi N; Ishido M; Suzuki F; Kaneko K; Kubota T; Miyasaka N; Nanki T
Arthritis Rheum; 2009 Oct; 60(10):3118-27. PubMed ID: 19790078
[TBL] [Abstract][Full Text] [Related]
10. A novel anticancer effect of thalidomide: inhibition of intercellular adhesion molecule-1-mediated cell invasion and metastasis through suppression of nuclear factor-kappaB.
Lin YC; Shun CT; Wu MS; Chen CC
Clin Cancer Res; 2006 Dec; 12(23):7165-73. PubMed ID: 17145842
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of subtype-selective cyclooxygenase (COX) inhibitors derived from thalidomide.
Sano H; Noguchi T; Tanatani A; Hashimoto Y; Miyachi H
Bioorg Med Chem; 2005 May; 13(9):3079-91. PubMed ID: 15809144
[TBL] [Abstract][Full Text] [Related]
12. All-trans retinoic acid is a ligand for the orphan nuclear receptor ROR beta.
Stehlin-Gaon C; Willmann D; Zeyer D; Sanglier S; Van Dorsselaer A; Renaud JP; Moras D; Schüle R
Nat Struct Biol; 2003 Oct; 10(10):820-5. PubMed ID: 12958591
[TBL] [Abstract][Full Text] [Related]
13. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity.
Sulová Z; Macejová D; Seres M; Sedlák J; Brtko J; Breier A
Toxicol In Vitro; 2008 Feb; 22(1):96-105. PubMed ID: 17920233
[TBL] [Abstract][Full Text] [Related]
14. Novel biological response modifiers derived from thalidomide.
Hashimoto Y
Curr Med Chem; 1998 Jun; 5(3):163-78. PubMed ID: 9562600
[TBL] [Abstract][Full Text] [Related]
15. Retinoids: potential in cancer prevention and therapy.
Clarke N; Germain P; Altucci L; Gronemeyer H
Expert Rev Mol Med; 2004 Nov; 6(25):1-23. PubMed ID: 15569396
[TBL] [Abstract][Full Text] [Related]
16. Vitamin A regulation of gene expression: molecular mechanism of a prototype gene.
McGrane MM
J Nutr Biochem; 2007 Aug; 18(8):497-508. PubMed ID: 17320364
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional activities of retinoic acid receptors.
Lefebvre P; Martin PJ; Flajollet S; Dedieu S; Billaut X; Lefebvre B
Vitam Horm; 2005; 70():199-264. PubMed ID: 15727806
[TBL] [Abstract][Full Text] [Related]
18. Retinoids and TRAIL: two cooperating actors to fight against cancer.
Altucci L; Gronemeyer H
Vitam Horm; 2004; 67():319-45. PubMed ID: 15110184
[TBL] [Abstract][Full Text] [Related]
19. Retinoids for the treatment of psoriasis: outlook for the future.
Kuenzli S; Saurat JH
Curr Opin Investig Drugs; 2001 May; 2(5):625-30. PubMed ID: 11569936
[TBL] [Abstract][Full Text] [Related]
20. Retinoids inhibit measles virus in vitro via nuclear retinoid receptor signaling pathways.
Trottier C; Chabot S; Mann KK; Colombo M; Chatterjee A; Miller WH; Ward BJ
Antiviral Res; 2008 Oct; 80(1):45-53. PubMed ID: 18547655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]